Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis

Circulation
Eswar KrishnanGurkirpal Singh

Abstract

Patients with rheumatoid arthritis are at high risk for acute myocardial infarction (AMI). The treatment of rheumatoid arthritis has become more intensive over the past 2 decades, resulting in tighter control of inflammation and lower levels of disability. The impact of this on atherosclerotic cardiovascular diseases is not known. Death rates from AMI in a cohort of 3862 patients with rheumatoid arthritis followed up from 1980 to 1997 were studied. Time trends in AMI mortality among successive incidence and birth cohorts were examined by use of multivariable Poisson regression models and by comparing standardized mortality ratios. The mean age was 56 years in this predominantly female cohort (76%), and median disease duration was 6.5 years. During the period of observation, the use of methotrexate increased substantially, whereas that of prednisone was relatively stable. Over the 22,209 person-years of observation, there were 157 deaths as a result of AMI, with a death rate of 7.06 per 1000 person-years. Mortality rates were higher in older age groups and in men. After adjustment for age, sex, race, and disease duration, the risk of AMI declined in successive incidence years (relative risk, 0.94; 95% CI, 0.92 to 0.96). Patients...Continue Reading

References

Jan 1, 1977·Scandinavian Journal of Rheumatology·K KootaO Mutru
Jun 15, 1985·British Medical Journal·O MutruK Koota
Sep 1, 1974·Arthritis and Rheumatism·R F Davis, E G Engleman
Apr 1, 1994·Arthritis and Rheumatism·F WolfeM A Cathey
Jan 1, 1995·Lifetime Data Analysis·M L Moeschberger, J P Klein
May 27, 1999·Annals of the Rheumatic Diseases·E Lindqvist, K Eberhardt
Mar 18, 2000·Scandinavian Journal of Rheumatology·A G KvalvikD P Symmons
Jun 16, 2001·Arthritis and Rheumatism·T PincusF Wolfe
Feb 16, 2002·Heart·N T Mulvihill, J B Foley
Mar 29, 2002·Arthritis and Rheumatism·Michele F DoranSherine E Gabriel
Apr 16, 2002·Arthritis and Rheumatism·S Van DoornumI P Wicks
Mar 12, 2003·Circulation·Daniel H SolomonGary C Curhan
Oct 1, 1953·The New England Journal of Medicine·S COBBW BAUER

❮ Previous
Next ❯

Citations

Aug 22, 2008·Rheumatology International·R KoivuniemiM Leirisalo-Repo
Sep 18, 2009·Clinical Rheumatology·Riitta KoivuniemiMarjatta Leirisalo-Repo
Dec 12, 2012·Current Atherosclerosis Reports·Paul M Ridker
Apr 5, 2007·Nature Clinical Practice. Rheumatology·Frances C Hall
Feb 10, 2010·Nature Reviews. Rheumatology·Radjesh J BisoendialPaul Peter Tak
Jun 2, 2011·Nature Reviews. Rheumatology·Deborah P M Symmons, Sherine E Gabriel
Apr 5, 2008·Current Opinion in Rheumatology·Thomas Dörner, Gerd R Burmester
Apr 1, 1992·Australian and New Zealand Journal of Medicine·S C Greaves, D N Sharpe
Aug 14, 2010·International Journal of Rheumatic Diseases·N Hanim MaK H Sim
Aug 5, 2005·Annals of the Rheumatic Diseases·K M J DouglasG D Kitas
Jun 24, 2006·Annals of the Rheumatic Diseases·D H SolomonS Schneeweiss
Feb 28, 2007·Annals of the Rheumatic Diseases·Loreto CarmonaUNKNOWN BIOBADASER and EMECAR Groups
Jun 1, 2010·Therapeutic Advances in Musculoskeletal Disease·Awal Al Husain, Ian N Bruce
May 3, 2013·BMC Medicine·Johan Frostegård
Sep 15, 2007·Arthritis Research & Therapy·Loic Guillevin, Thomas Dörner
Jul 5, 2011·Arthritis Research & Therapy·Johan Frostegård
Feb 19, 2013·The Journal of Rheumatology·Sara S McCoySherine E Gabriel
Apr 19, 2011·Current Opinion in Cardiology·Holly JohnGeorge D Kitas
Feb 8, 2006·Current Opinion in Rheumatology·Nicola J Goodson, Daniel H Solomon
Oct 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·David L Scott, Heidi Lempp
May 17, 2013·Expert Opinion on Emerging Drugs·Jeremy P BermanRobert S Rosenson
Jul 29, 2010·Current Medical Research and Opinion·Jeanette H MagnusSudesh K Srivastav
Jul 14, 2012·Reumatología clinica·Esther ToledanoJuan Ángel Jover
May 1, 2009·Reumatología clinica·Miguel A González-Gay, Carlos González-Juanatey
Oct 24, 2008·The American Journal of Medicine·Jane E Salmon, Mary J Roman
Apr 9, 2008·The American Journal of Cardiology·Subhash BanerjeeSalahuddin Kazi
Nov 28, 2008·Arthritis and Rheumatism·J Antonio Aviña-ZubietaDiane Lacaille
Jul 28, 2006·Arthritis and Rheumatism·Eswar KrishnanH Ralph Schumacher
Sep 26, 2007·Annals of the New York Academy of Sciences·Roberto GerliYehuda Shoenfeld

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.